Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Metsera reports $156.26 million loss in first nine months of 2024 Proceeds from IPO to fund MET-097i clinical trials Weight ... New York City-based biotech firm is developing injectable and oral ...

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs ... of the two most popular weight loss drugs, Ozempic and Wegovy.

New year, new you! Getting healthy is a popular resolution and to meet goals, some people may turn to weight-loss drugs for help. As certain weight-loss drugs have become increasingly popular ...

Indianapolis-based Eli Lilly and Co. is projecting approval of its experimental weight ... loss pill as soon as early 2026, CEO Dave Ricks said, one of several in a new generation of the popular ...

A weight loss pill would offer more convenience to patients and would be easier to manufacture. The company is set to release key late-stage trial data on the drug, orforglipron, by the middle of ...